Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Double-Blind Placebo-Controlled Study of CCX140-B in Type 2 Diabetes Mellitus with Albuminuria
2011-003049-16Phase 2Completed
- Sponsor
- ChemoCentryx
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and diabetic glomerulosclerosis comparing CCX140-B with Placebo (2 arms). Primary endpoint: Urinary albumin excretion. Started Aug 2011; status: completed.
02
Drugs
ilacirnon
03
Conditions
type 2 diabetes mellitus (T2DM)diabetic glomerulosclerosis
Beyond the preview
Go deeper on 2011-003049-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003049-16.